Standard Biotools (LAB) Gains from Investment Securities (2012 - 2025)
Standard Biotools (LAB) reported Gains from Investment Securities of -$180000.0 for Q4 2025, down 446.15% year-over-year from $52000.0 in Q4 2024, and down 101.72% quarter-over-quarter from $10.4 million in Q3 2025.
Standard Biotools (LAB) Gains from Investment Securities (2012 - 2025) Analysis & Trends
Standard Biotools (LAB) has 14 years of Gains from Investment Securities data on file, last reported at -$180000.0 in Q4 2025.
- Gains from Investment Securities for Q4 2025 came in at -$180000.0, down 446.15% year-over-year; the trailing twelve-month figure through Mar 2026 was -$360000.0 (down 192.07% YoY), and the FY2025 annual result was $32.5 million, down 17.0% from the prior year.
- Gains from Investment Securities fell to -$180000.0 in Q4 2025 per LAB's latest filing, from $10.4 million in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $10.4 million in Q3 2025 and troughed at -$629000.0 in Q4 2023.
- A 5-year average of $2.2 million and a median of $200000.0 in 2023 frame the typical range for Gains from Investment Securities.
- On a YoY basis, Gains from Investment Securities climbed as much as 309413.93% in 2025 and fell as far as 39894.17% in 2025.
- A 5-year view of Gains from Investment Securities shows it stood at $1.5 million in 2021, then jumped by 401.56% to $7.7 million in 2022, then sank by 108.15% to -$629000.0 in 2023, then soared by 108.27% to $52000.0 in 2024, then plunged by 446.15% to -$180000.0 in 2025.
- Business Quant data shows LAB's Gains from Investment Securities at -$180000.0 in Q4 2025, $10.4 million in Q3 2025, and $8.9 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | Standard Biotools | 344.96 Mn | -110.22 Mn | 11.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -180,000.00 |
| Dec 31, 2025 | -180,000.00 |
| Sep 30, 2025 | 10.44 Mn |
| Sep 30, 2025 | 10.44 Mn |
| Jun 30, 2025 | 8.94 Mn |
| Jun 30, 2025 | 8.94 Mn |
| Mar 31, 2025 | -232,000.00 |
| Mar 31, 2025 | -232,000.00 |
| Dec 31, 2024 | 52,000.00 |
| Dec 31, 2024 | 52,000.00 |
| Sep 30, 2024 | 3,374.00 |
| Sep 30, 2024 | 3,374.00 |
| Jun 30, 2024 | 1.20 Mn |
| Jun 30, 2024 | 1.20 Mn |
| Mar 31, 2024 | 583.00 |
| Mar 31, 2024 | 583.00 |
| Dec 31, 2023 | -629,000.00 |
| Dec 31, 2023 | -629,000.00 |
| Sep 30, 2023 | 9.25 Mn |
| Sep 30, 2023 | 9.25 Mn |